Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BAXTER INTERNATIONAL INCBAX · Entity 1707 | Director | May 05, 2026 | May 07, 2026 |
| Encompass Health CorpEHC · Entity 3460 | Director | July 15, 2026 | July 16, 2026 |
| Pear Therapeutics, Inc.PEAR · Entity 114512 | Director | February 15, 2023 | February 17, 2023 |
| Walgreens Boots Alliance, Inc.WBA · Entity 16467 | Director | August 13, 2025 | August 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BAXTER INTERNATIONAL INC
Report date May 05, 2026 · Filed May 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1 par valueSEC Table I · non-derivative | Direct | 34,994 |
Reported balance
After 2026-05-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-05 · Grant · Acquired 12,836 · Balance 34,994 F1: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. F2: Total includes the automatic reinvestment of dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
F2: Total includes the automatic reinvestment of dividends.
Encompass Health Corp
Report date July 15, 2026 · Filed July 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Encompass Health Common StockSEC Table I · non-derivative | Direct | 22,972 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 40 · Balance 22,972 F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.
Pear Therapeutics, Inc.
Report date February 15, 2023 · Filed February 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 66,666 |
Reported balance
After 2023-02-15 transaction · row 1
1 source rowRow 1 · 2023-02-15 · Grant · Acquired 66,666 · Balance 66,666 |
Walgreens Boots Alliance, Inc.
Report date August 13, 2025 · Filed August 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,961 |
Reported balance
After 2025-08-13 transaction · row 1
1 source rowRow 1 · 2025-08-13 · Grant · Acquired 16,820 · Balance 37,961 F1: Annual share grant issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan in arrears with respect to services rendered over the course of the prior year. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual share grant issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan in arrears with respect to services rendered over the course of the prior year.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Hill-Rom Holdings, Inc.
Report date December 13, 2021 · Filed December 15, 2021
Section 16 reporting ended · disclosed 2021-12-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (03/14/2017)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-12-13 · Disposition to issuer · Disposed 2,762 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Restricted Stock Units (03/07/2018)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-12-13 · Disposition to issuer · Disposed 2,184 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Restricted Stock Units (03/06/2019)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-12-13 · Disposition to issuer · Disposed 1,762 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Restricted Stock Units (02/26/2020)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-12-13 · Disposition to issuer · Disposed 1,870 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Restricted Stock Units (03/11/2021)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-12-13 · Disposition to issuer · Disposed 1,798 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2021-12-13 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock.
F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2021 Filed Mar 12, 2021 16:05 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantNon-Employee Restricted Stock Units (Deferred Stock Award) · Derivative | 1,787 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000047518-21-000033 · wf-form4_161558306988404.xml · derivative · entry 2 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,787 Underlying: Common Stock · 1,787 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · kind: Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. F3 · derivative.exercise_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. F3 · derivative.expiration_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:41 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 28 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002092 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,173 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| November 01, 2020 Filed Nov 2, 2020 16:45 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantCommon Stock | 5,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001618921-20-000128 · wf-form4_160435347683307.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,069 F1 · kind: Shares issued as non-employee director compensation under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan. Read SEC document |
| October 16, 2020 Filed Oct 20, 2020 14:42 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-027250 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,145 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $68.11. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 21:11 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 35 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-021834 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,111 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $65.21. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| May 06, 2020 Filed May 7, 2020 21:49 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 2,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015814 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,076 F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 13:18 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 24 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-013962 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,772 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $69.76. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| February 26, 2020 Filed Feb 26, 2020 16:48 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantNon-Employee Restricted Stock Units (Deferred Stock Award) · Derivative | 1,842 | $0.00 | $0.00 |
DisclosureSEC source: 0000047518-20-000032 · wf-form4_158275369984759.xml · derivative · entry 2 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,842 Underlying: Common Stock · 1,842 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · kind: Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. F3 · derivative.exercise_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. F3 · derivative.expiration_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 14:25 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 21 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-002001 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,748 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $77.50. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 17:41 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantCommon Stock | 3,485 | $0.00 | $0.00 |
DisclosureSEC source: 0001618921-19-000104 · edgar.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,194 F1 · kind: Shares issued as non-employee director compensation under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan. Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 15:27 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 25 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030674 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,727 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2019, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $64.71. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 16, 2019 Filed Jul 17, 2019 22:16 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 24 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-024805 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,702 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $64.39. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| May 03, 2019 Filed May 7, 2019 16:04 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 2,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-017547 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,678 F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| April 23, 2019 Filed Apr 24, 2019 13:13 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-016101 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,351 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 16:27 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantNon-Employee Restricted Stock Units (Deferred Stock Award) · Derivative | 1,722 | $0.00 | $0.00 |
DisclosureSEC source: 0000047518-19-000019 · wf-form4_155208044144732.xml · derivative · entry 2 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,722 Underlying: Common Stock · 1,722 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · kind: Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. F3 · derivative.exercise_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. F3 · derivative.expiration_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:12 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-002130 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,336 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| November 20, 2018 Filed Nov 23, 2018 16:01 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | SaleCommon Stock | 7,050 | $78.81 | $555,610.50 |
DisclosureSEC source: 0001618921-18-000091 · edgar.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,709 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.79 to $78.84, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or any securityholder of the issuer, upon request, information regarding the number of shares sold at each price within the range indicated. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 17:01 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantCommon Stock | 2,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001618921-18-000083 · edgar.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,759 F1 · kind: Shares issued as non-employee director compensation under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan. Read SEC document |
| October 15, 2018 Filed Oct 17, 2018 20:03 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-030497 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,322 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2018, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 20:10 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-023502 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,309 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| May 04, 2018 Filed May 7, 2018 21:03 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 3,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-016522 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,297 F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| March 07, 2018 Filed Mar 9, 2018 16:59 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantNon-Employee Restricted Stock Units (Deferred Stock Award) · Derivative | 2,116 | $0.00 | $0.00 |
DisclosureSEC source: 0000047518-18-000027 · wf-form4_152063272110483.xml · derivative · entry 2 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,116 Underlying: Common Stock · 2,116 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · kind: Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. F3 · derivative.exercise_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. F3 · derivative.expiration_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 17:26 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantCommon Stock | 2,984 | $0.00 | $0.00 |
DisclosureSEC source: 0001618921-17-000097 · edgar.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,256 F1 · kind: Shares issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended. Read SEC document |
| October 24, 2017 Filed Oct 25, 2017 18:48 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 445.831 | $67.29 | $29,999.97 |
DisclosureSEC source: 0001618921-17-000074 · edgar.xml · derivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,985.2 Underlying: Common Stock · 445.831 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (including the applicable election forms thereunder, the "Plan"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3 · balance_after: Includes phantom stock units issued in lieu of dividends (through September 30, 2017) on outstanding phantom stock units. Read SEC document |
| July 12, 2017 Filed Jul 13, 2017 17:08 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 370.872 | $77.52 | $28,750.00 |
DisclosureSEC source: 0001618921-17-000056 · edgar.xml · derivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,272.1 Underlying: Common Stock · 370.872 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (including the applicable election forms thereunder, the "Plan"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3 · balance_after: Includes phantom stock units issued in lieu of dividends (through June 30, 2017) on outstanding phantom stock units. Read SEC document |
| April 20, 2017 Filed Apr 21, 2017 16:58 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 341.692 | $84.14 | $28,749.96 |
DisclosureSEC source: 0001618921-17-000041 · edgar.xml · derivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,650.7 Underlying: Common Stock · 341.692 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (including the applicable election forms thereunder, the "Plan"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3 · balance_after: Includes phantom stock units issued in lieu of dividends (through March 31, 2017) on outstanding phantom stock units. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 16:59 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantNon-Employee Restricted Stock Units (Deferred Stock Award) · Derivative | 2,651 | $0.00 | $0.00 |
DisclosureSEC source: 0000047518-17-000032 · wf-form4_148969797124684.xml · derivative · entry 2 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,651 Underlying: Common Stock · 2,651 shares Expires not disclosed F1 · derivative.exercise_price: Conversion or exercise price of the restricted stock units is 1-for-1. F2 · kind: Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. F3 · derivative.exercise_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. F3 · derivative.expiration_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. Read SEC document |
| January 26, 2017 Filed Jan 27, 2017 17:11 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 353.759 | $81.27 | $28,749.99 |
DisclosureSEC source: 0001618921-17-000010 · edgar.xml · derivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,072.3 Underlying: Common Stock · 353.759 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (including the applicable election forms thereunder, the "Plan"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3 · balance_after: Includes phantom stock units issued in lieu of dividends (through January 15, 2017) on outstanding phantom stock units. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 17:04 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantCommon Stock | 2,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001618921-16-000087 · edgar.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,272 F1 · kind: Shares issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended. Read SEC document |
| October 12, 2016 Filed Oct 13, 2016 18:19 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 367.178 | $78.30 | $28,750.04 |
DisclosureSEC source: 0001618921-16-000056 · edgar.xml · derivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,487 Underlying: Common Stock · 367.178 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (including the applicable election forms thereunder, the "Plan"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3 · balance_after: Includes phantom stock units issued in lieu of dividends (through September 30, 2016) on outstanding phantom stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.